Kenneth Kosik News Today

Looking back on some of the most interesting STEM events UCSB has hosted over the last academic year.

Macrophage cells are on the front lines when the immune system kicks in. They’re a type of white blood cell that phagocytize—or fully engulf—foreign cells. Moreover, scientists have observed another macrophage behavior, in which they “nibble” on pathogens by biting off small chunks at a time.

The discovery of a gene variant that protects against an early, insidious form of Alzheimers could lead to new treatments for the disease.

The 10th annual Appel Alzheimer's Disease Research Institute Symposium brought fascinating reports of progress in understanding Alzheimer's and related neurodegenerative diseases.

Noncoding RNAs are proving to be critical players in the evolution of brain anatomy and cognitive complexity.

Check out the dynamic arts performances and events that Holy Cross has lined up.

Jennifer Rauch, assistant professor of biochemistry and molecular biology, is collaborating on a two-year, $700,000 National Institutes of Health grant to develop a new technology to treat Alzheimer’s disease, chronic traumatic encephalopathy and other neurodegenerative diseases.

February 25, 2021 at 8:00 am by Sean Crommelin Over the past two decades, American universities have become more racially diverse. From 1996 to 2016, the percentage of undergraduate students of color in the United States increased from 29.6% to 45.2%, according to a report by the American Council on Education. Currently, Tettegah and her collaborators have been gathering data from students as part of a broader self-assessment of UCSB’s current climate and practices.  Emily Liu...